175 related articles for article (PubMed ID: 26222311)
1. Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.
de Oliveira JT; Ribeiro C; Barros R; Gomes C; de Matos AJ; Reis CA; Rutteman GR; Gärtner F
PLoS One; 2015; 10(7):e0134458. PubMed ID: 26222311
[TBL] [Abstract][Full Text] [Related]
2. Coordinated expression of galectin-3 and galectin-3-binding sites in malignant mammary tumors: implications for tumor metastasis.
de Oliveira JT; de Matos AJ; Gomes J; Vilanova M; Hespanhol V; Manninen A; Rutteman G; Chammas R; Gärtner F; Bernardes ES
Glycobiology; 2010 Nov; 20(11):1341-52. PubMed ID: 20591828
[TBL] [Abstract][Full Text] [Related]
3. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking.
de Oliveira JT; de Matos AJ; Santos AL; Pinto R; Gomes J; Hespanhol V; Chammas R; Manninen A; Bernardes ES; Albuquerque Reis C; Rutteman G; Gärtner F
Int J Dev Biol; 2011; 55(7-9):823-34. PubMed ID: 22161838
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors.
DE Oliveira JT; DE Matos AJ; Barros R; Ribeiro C; Chen A; Hespanhol V; Rutteman GR; Gärtner F
Anticancer Res; 2014 May; 34(5):2211-21. PubMed ID: 24778023
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression.
Wang L; Li YS; Yu LG; Zhang XK; Zhao L; Gong FL; Yang XX; Guo XL
Biochem Pharmacol; 2020 Aug; 178():114113. PubMed ID: 32579956
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival.
Ikemori RY; Machado CM; Furuzawa KM; Nonogaki S; Osinaga E; Umezawa K; de Carvalho MA; Verinaud L; Chammas R
PLoS One; 2014; 9(11):e111592. PubMed ID: 25369297
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of galectin-3 in canine mammary tumours.
Choi YK; Hong SH; Kim BH; Kim HC; Woo HJ; Kim DY
J Comp Pathol; 2004; 131(2-3):242-5. PubMed ID: 15276865
[TBL] [Abstract][Full Text] [Related]
8. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.
Irie A; Yamauchi A; Kontani K; Kihara M; Liu D; Shirato Y; Seki M; Nishi N; Nakamura T; Yokomise H; Hirashima M
Clin Cancer Res; 2005 Apr; 11(8):2962-8. PubMed ID: 15837748
[TBL] [Abstract][Full Text] [Related]
9. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
Shekhar MP; Nangia-Makker P; Tait L; Miller F; Raz A
Am J Pathol; 2004 Dec; 165(6):1931-41. PubMed ID: 15579437
[TBL] [Abstract][Full Text] [Related]
10. Serum Galectin-3 Levels in Dogs with Metastatic and Non-metastatic Mammary Tumors.
Ribeiro C; Santos MS; DE Matos AJ; Barros R; Gärtner F; Rutteman GR; DE Oliveira JT
In Vivo; 2016; 30(1):13-6. PubMed ID: 26709123
[TBL] [Abstract][Full Text] [Related]
11. Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice.
Eude-Le Parco I; Gendronneau G; Dang T; Delacour D; Thijssen VL; Edelmann W; Peuchmaur M; Poirier F
Glycobiology; 2009 Jan; 19(1):68-75. PubMed ID: 18849326
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression.
Kim SJ; Choi IJ; Cheong TC; Lee SJ; Lotan R; Park SH; Chun KH
Gastroenterology; 2010 Mar; 138(3):1035-45.e1-2. PubMed ID: 19818782
[TBL] [Abstract][Full Text] [Related]
13. Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer.
John CM; Leffler H; Kahl-Knutsson B; Svensson I; Jarvis GA
Clin Cancer Res; 2003 Jun; 9(6):2374-83. PubMed ID: 12796408
[TBL] [Abstract][Full Text] [Related]
14. On the role of galectin-3 in cancer apoptosis.
Nakahara S; Oka N; Raz A
Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone receptor (GHR) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line.
Pawłowski KM; Popielarz D; Szyszko K; Gajewska M; Motyl T; Król M
Vet Comp Oncol; 2012 Mar; 10(1):2-15. PubMed ID: 22235976
[TBL] [Abstract][Full Text] [Related]
16. Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells.
Qiao L; Liang N; Xie J; Luo H; Zhang J; Deng G; Li Y; Zhang J
Mol Med Rep; 2016 Jan; 13(1):160-6. PubMed ID: 26718452
[TBL] [Abstract][Full Text] [Related]
17. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
18. Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.
Sharp JA; Mailer SL; Thomson PC; Lefèvre C; Nicholas KR
Mol Cancer; 2008 Jan; 7():1. PubMed ID: 18179684
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
20. Alterations in CDK1 expression and nuclear/nucleolar localization following induction in a spontaneous canine mammary cancer model.
Migone F; Deinnocentes P; Smith BF; Bird RC
J Cell Biochem; 2006 Jun; 98(3):504-18. PubMed ID: 16317763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
